[go: up one dir, main page]

IT1318504B1 - Metodo e apparecchiatura per la diagnosi precoce di tumori vescicalisu campioni di urina. - Google Patents

Metodo e apparecchiatura per la diagnosi precoce di tumori vescicalisu campioni di urina.

Info

Publication number
IT1318504B1
IT1318504B1 IT2000MI001002A ITMI20001002A IT1318504B1 IT 1318504 B1 IT1318504 B1 IT 1318504B1 IT 2000MI001002 A IT2000MI001002 A IT 2000MI001002A IT MI20001002 A ITMI20001002 A IT MI20001002A IT 1318504 B1 IT1318504 B1 IT 1318504B1
Authority
IT
Italy
Prior art keywords
marker
early diagnosis
equipment
urine samples
bladder tumors
Prior art date
Application number
IT2000MI001002A
Other languages
English (en)
Inventor
Giorgio Stanta
Original Assignee
Talent Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Talent Srl filed Critical Talent Srl
Priority to IT2000MI001002A priority Critical patent/IT1318504B1/it
Publication of ITMI20001002A0 publication Critical patent/ITMI20001002A0/it
Priority to EP01949312A priority patent/EP1281087B1/en
Priority to AT01949312T priority patent/ATE383578T1/de
Priority to AU2001270505A priority patent/AU2001270505A1/en
Priority to PCT/EP2001/005054 priority patent/WO2001086288A2/en
Priority to DE60132323T priority patent/DE60132323D1/de
Publication of ITMI20001002A1 publication Critical patent/ITMI20001002A1/it
Application granted granted Critical
Publication of IT1318504B1 publication Critical patent/IT1318504B1/it

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4742Keratin; Cytokeratin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70514CD4
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
IT2000MI001002A 2000-05-08 2000-05-08 Metodo e apparecchiatura per la diagnosi precoce di tumori vescicalisu campioni di urina. IT1318504B1 (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT2000MI001002A IT1318504B1 (it) 2000-05-08 2000-05-08 Metodo e apparecchiatura per la diagnosi precoce di tumori vescicalisu campioni di urina.
EP01949312A EP1281087B1 (en) 2000-05-08 2001-05-04 Early diagnosis of bladder tumor in urine samples
AT01949312T ATE383578T1 (de) 2000-05-08 2001-05-04 Frühen diagnose von blasentumor in urinproben
AU2001270505A AU2001270505A1 (en) 2000-05-08 2001-05-04 Method and apparatus for early diagnosis of bladder tumor in urine samples
PCT/EP2001/005054 WO2001086288A2 (en) 2000-05-08 2001-05-04 Early diagnosis of bladder tumor in urine samples
DE60132323T DE60132323D1 (de) 2000-05-08 2001-05-04 Frühen diagnose von blasentumor in urinproben

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI001002A IT1318504B1 (it) 2000-05-08 2000-05-08 Metodo e apparecchiatura per la diagnosi precoce di tumori vescicalisu campioni di urina.

Publications (3)

Publication Number Publication Date
ITMI20001002A0 ITMI20001002A0 (it) 2000-05-08
ITMI20001002A1 ITMI20001002A1 (it) 2001-11-08
IT1318504B1 true IT1318504B1 (it) 2003-08-27

Family

ID=11444995

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000MI001002A IT1318504B1 (it) 2000-05-08 2000-05-08 Metodo e apparecchiatura per la diagnosi precoce di tumori vescicalisu campioni di urina.

Country Status (6)

Country Link
EP (1) EP1281087B1 (it)
AT (1) ATE383578T1 (it)
AU (1) AU2001270505A1 (it)
DE (1) DE60132323D1 (it)
IT (1) IT1318504B1 (it)
WO (1) WO2001086288A2 (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1355158A1 (de) 2002-04-19 2003-10-22 B.R.A.H.M.S Aktiengesellschaft Verfahren zur Diagnose von Entzündungserkrankungen und Infektionen unter Bestimmung des Phosphoproteins LASP-1 als Inflammationsmarker
US7217515B2 (en) 2002-09-30 2007-05-15 Chi Mei Foundation Medical Center HURP gene as a molecular marker for bladder cancer
ES2538504T3 (es) * 2004-07-23 2015-06-22 Pacific Edge Limited Marcadores en la orina para la detección del cáncer de vejiga
ES2304306B1 (es) * 2007-03-20 2009-07-07 Indas Biotech, S.L.U. Metodo de diagnostico y/o pronostico de cancer vesical.
GB201814040D0 (en) * 2018-08-29 2018-10-10 Oncologica Uk Ltd Testing and therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863726A (en) * 1993-11-12 1999-01-26 Geron Corporation Telomerase activity assays
JPH09262100A (ja) * 1996-03-27 1997-10-07 Mount Sinai School Medicine City Univ New York テロメラーゼ活性の存在を測定することによる尿試料中のヒト膀胱癌細胞の検出方法
ATE309389T1 (de) * 1996-06-28 2005-11-15 Rebio Gen Inc Verfahren zum entdecken von telomerase-aktivität
CN1291231B (zh) * 1996-10-01 2010-06-02 杰龙公司 人类的端粒酶催化亚单位
DE19757300A1 (de) * 1997-12-22 1999-06-24 Roche Diagnostics Gmbh Nachweis von Harnblasenkarzinom in einer Urinprobe

Also Published As

Publication number Publication date
DE60132323D1 (de) 2008-02-21
ITMI20001002A0 (it) 2000-05-08
AU2001270505A1 (en) 2001-11-20
WO2001086288A2 (en) 2001-11-15
EP1281087B1 (en) 2008-01-09
ITMI20001002A1 (it) 2001-11-08
EP1281087A2 (en) 2003-02-05
WO2001086288A3 (en) 2002-05-16
ATE383578T1 (de) 2008-01-15

Similar Documents

Publication Publication Date Title
ATE419388T1 (de) Nukleinsäureanreicherung
EP1288313A3 (en) System and method for assaying nucleic acid molecules
WO2003008622A3 (en) Exponential nucleic acid amplification using nicking endonucleases
SE0000538D0 (sv) Methods and kits for proximity probing
AU6152301A (en) Detection of nucleic acid hybridization by fluorescence polarization
DE60120501D1 (de) mRNA AMPLIFIZIERUNG
PT2280283E (pt) Células marcadas para uso como controlo funcional interno em ensaios de deteção de células raras
DK1290444T3 (da) Toxicitetstypisering under anvendelse af lever-stamceller
WO2003048300A3 (en) Methods of identifying cellular target molecules
AU4322102A (en) Methods and devices for the quantitative detection of prostate specific membraneantigen and other prostatic markers
WO2003100006A3 (en) Method of improved prostate cancer detection
IT1318504B1 (it) Metodo e apparecchiatura per la diagnosi precoce di tumori vescicalisu campioni di urina.
ATE513851T1 (de) Menschliches gen zur fruchtbarkeit entscheidend
DK1214447T3 (da) Påvisning af pyruvatkinase-isoenzymer i fæces
ATE538217T1 (de) Erkennung von ektopischen schwangerschaften
DE50115166D1 (de) System zur einfachen Nukleinsäureanalytik
AU2003264512A1 (en) Method of detecting colon cancer marker
EP1609874A3 (en) System for searching for and identifying pathogenic agents
WO2005033330A3 (en) Fluorescent probes for use in protein kinase inhibitor binding assay
WO2006034456A3 (en) Compositions and methods for detecting and treating tumors
Zhang et al. Proteomic profiling of potential molecular targets of methyl-selenium compounds in the transgenic adenocarcinoma of mouse prostate model
WO2002077285A3 (en) Methods of determining the presence of polynucleotides employing amplification
DK1337849T3 (da) Fremgangsmåder og sammensætninger til at sortere og/eller bestemme mikroorganismer
NO20052553D0 (no) Cobalaminanalyse.
ES2169146T3 (es) Iniciadores y sondas destinadas para la amplificacion y para la deteccion del acido nucleico del citomegalovirus.